The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
A bipartisan group of state health policymakers from both the executive and legislative branches who are focused on improving population health.
Networks of state officials, advocates, and others aiming to invest in and transform primary care.
A program dedicated to advancing state-based efforts to make health care more affordable for residents, employers, and states.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
A leadership development program for early and mid-career state government officials who are committed to improving the health of all people in their communities.
A leadership program for senior state government officials who are committed to improving population health.
The Fund focuses on creating an affordable health care system built on strong primary care and partnerships that improve health outcomes for all.
Improving state leaders’ ability to enact and implement evidence-based health policies.
Advancing policies that create a more prevention- and primary care-oriented health system.
Improving population health through policies that contain health care cost growth.
Our state health policy resources offer relevant data analysis and best practices.
The Fund publishes reports, issues briefs, and case studies on state health policy issues.
Short takes on health policy issues from Milbank staff and guest authors.
Insights from Milbank President Debra Lubar on state health policymaking.
Reported articles and Q&As on timely health policy issues, as well as foundation updates.
Milbank Memorial Fund and Milbank Quarterly webinars featuring state health policymakers and researchers.
Updates and expert contact information for reporters.
The Milbank Memorial Fund is a private foundation that works to improve population health and health equity.
June 2023 John E. McDonough,
Has anti-monopoly become a bonafide political movement in the United States? About 300 persons who gathered at the Renaissance Hotel in Washington, DC, on May 4th say yes. Representing diverse organizations and backgrounds, they assembled for a daylong exploration of progress in restoring an aggressive national effort to thwart corporate monopoly across the US economy. More
June 2023 Paula M. Lantz,
The sunsetting of emergency declarations and orders, while signaling a decrease in the turmoil caused by COVID-19, does not mean the pandemic is over in the United States or globally. More
May 2023 Sandro Galea,
At some level, we failed at prevention during the COVID-19 pandemic. If our metric for success was preventing viral spread, illness, or death, then a pandemic in which the United States was hit harder than any other large country showed us that we fell substantially shorter in prevention than we might have hoped. With this as a motivating impulse, I suggest that we ask two questions: what caused the consequences of COVID-19 to be so devastating in the US? And, understanding that, what would be an intellectual and practical agenda for prevention going forward? More
May 2023 Joshua N. Auerbach, Joshua M. Sharfstein,
Two recent, much-discussed decisions from federal courts in Texas—one striking down the Affordable Care Act’s requirements for insurance coverage of preventive health services, the other invalidating the US Food and Drug Administration’s approval of the abortion drug mifepristone—illustrate a deepening tension between the public health community and the courts. Both decisions are now on appeal and may not ultimately be affirmed. More
April 2023 Dalton Conley,
Since before Ponce de Leon’s quest for the fountain of youth that led him to discover what is now Florida and Cervantes’ Don Quixote’s likeminded search, humans have sought a way to slow or even reverse the aging process. Now, however, we have preliminary evidence that there are indeed methods of slowing down senescence. More
March 2023 David Rosner,
A recent set of lawsuits against the Monsanto Corporation by local and state governments to get the company to clean up the mess it made of waterways and local schools with polychlorinated hydrocarbons (PCB) pollution has led to efforts by the company to silence scientists who have served as expert witnesses for plaintiffs. More
March 2023 Harold A. Pollack, Mai Pho, Mary Beth Shapley,
As intervention researchers, what do we owe our most vulnerable, most socially marginalized study subjects? These men and women confront the ravages… More
February 2023 Sara Rosenbaum,
On February 2, 2023, the Biden administration published a proposed rule that represents the latest chapter in a long-running war over the Affordable Care Act’s guarantee of free contraceptive coverage . More
January 2023 Gail R. Wilensky,
Protecting the confidentiality and integrity of business networks, data, and devices from cybersecurity intrusion has become a requirement in today’s business environment. It is especially important to be vigilant in protecting the end users who typically are the easiest point of entry. More
November 2022 Sandro Galea,
Perhaps central to the resolution of the health challenges that emerged during COVID-19 shall be the trajectory of mental health disorders that increased during the pandemic. More